ABU DHABI, United Arab Emirates, March 7, 2010 /PRNewswire/ -- Today the Health Authority - Abu Dhabi (HAAD), the regulatory body of the healthcare sector in the Emirate of Abu Dhabi, and the European Association for the Study of Diabetes (EASD) confirmed that they will host the 1st International Abu Dhabi Diabetes Congress (ADDC), at the Emirates Palace in Abu Dhabi from 12th to 14th March 2010.

The three day conference will bring together over 20 leading experts from Europe, the USA and the UAE, including some of the world's leading researchers; Professor Clifford J Bailey of Aston University, UK; Professor Ele Ferrannini of the University of Pisa, Italy; and Prof. Luc Van Gaal of Antwerp University Hospital, Belgium, Ulf Smith, President of EASD and Phillip Halban from Switzerland.

The congress aims to address the identification, causes and prevention of diabetes mellitus, relating factors such as obesity and cardiovascular diseases and the latest in management and treatment strategies.

H.E. Engineer Zaid Al Siksek, CEO of HAAD said: At HAAD we are committed to supporting the continuing development of our healthcare professionals and combating the incidence of diabetes through education and training. We are delighted that Abu Dhabi's first international diabetes congress will be attended by some of the industry's great minds, and we are sure that all delegates will take back a wealth of experience and education to share with their patients and fellow colleagues.

According to the latest research, diabetes mellitus is the second leading cause of death in the UAE and affects approximately 25 per cent of UAE Nationals. Diabetes mellitus is the condition used to describe patients who have high blood sugar levels, due to poor absorption of glucose into the body. For this to occur, either the pancreas does not produce enough insulin which breaks down the glucose for absorption into the body, or the insulin that is produced doesn't work properly. Type I diabetes usually occurs earlier in life and results from the loss of pancreatic cells producing insulin, whilst Type II diabetes often occurs after the age of 40 and results from resistance to or insufficient production of insulin produced in the body.

Whilst diabetes mellitus has many causes and often results as a culmination of multiple risk factors, cardiovascular disease and obesity represent significant confounding factors for the incidence of Type II diabetes. In order to combat the high prevalence of this life threatening condition, a combination of management, lifestyle and pharmacological factors need to be addressed.

The 1st International Abu Dhabi Diabetes Congress will be an opportunity for healthcare professionals to observe and share best practice examples amongst peers, and take these examples back into their communities. For more information on the congress and to register for attendance please visit: http://www.addc.gr/site/

About Health Authority - Abu Dhabi (HAAD):

The Health Authority - Abu Dhabi (HAAD) is the regulatory body of the Healthcare Sector at the Emirate of Abu Dhabi and ensures excellence in Healthcare for the community by monitoring the health status of the population. HAAD defines the strategy for the health system, monitors and analyses the health status of the population and performance of the system. In addition HAAD shapes the regulatory framework for the health system, inspects against regulations, enforce standards, and encourages adoption of world - class best practices and performance targets by all healthcare service providers in the Emirate. HAAD also drives programs to increase awareness and adoption of healthy living standards among the residents of the Emirate of Abu Dhabi in addition to regulating scope of services, premiums and reimbursement rates of the health system in the Emirate of Abu Dhabi.

SOURCE: Health Authority - Abu Dhabi

CONTACT: Rami Adwan, Media Specialist of Health Authority - Abu Dhabi,+971-2-4913-318, or radwan@haad.ae